The perspective of clinical pharmacologist: what is the safety of complex polypharmacy in hospitalized COVID-19 patients?
O. Kovalenko (Dnipro, Ukraine), V. Rudakova (Dnipro, Ukraine), K. Suska (Dnipro, Ukraine), K. Gashynova (Dnipro, Ukraine), N. But (Dnipro, Ukraine)
Source: International Congress 2022 – Chronic cough, airway diseases and methods
Session: Chronic cough, airway diseases and methods
Session type: Thematic Poster
Number: 186
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Kovalenko (Dnipro, Ukraine), V. Rudakova (Dnipro, Ukraine), K. Suska (Dnipro, Ukraine), K. Gashynova (Dnipro, Ukraine), N. But (Dnipro, Ukraine). The perspective of clinical pharmacologist: what is the safety of complex polypharmacy in hospitalized COVID-19 patients?. 186
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|